Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders Equity - USD ($) $ in Thousands	Series A Convertible Preferred Stock Preferred Stock	Series B Convertible Preferred Stock Preferred Stock	Common Stock	Additional Paid-in Capital	Treasury Stock, Common	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total
Stockholders equity, Beginning balance at Dec. 31, 2020	$ 32,373	$ 64,815		$ 66			$ (23,147)	$ (23,081)
Stockholders equity, Beginning balance (in shares) at Dec. 31, 2020	32,450,000	34,043,889	800,679
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock				5				5
Vesting of restricted common stock (in shares)			11,832
Stock-based compensation				882				882
Issuance of initial public offering common stock, net	$ (32,373)	$ (64,815)	$ 2	194,237				194,239
Issuance of initial public offering common stock, net (in shares)	(32,450,000)	(34,043,889)	22,389,460
Unrealized gain (loss) on marketable securities								0
Net loss							(22,417)	(22,417)
Stockholders equity, Ending balance at Sep. 30, 2021			$ 2	195,190			(45,564)	149,628
Stockholders equity, Ending balance (in shares) at Sep. 30, 2021			23,201,971
Stockholders equity, Beginning balance at Jun. 30, 2021			$ 2	188,632			(33,297)	155,337
Stockholders equity, Beginning balance (in shares) at Jun. 30, 2021			22,794,620
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock				1				1
Vesting of restricted common stock (in shares)			3,944
Stock-based compensation				659				659
Issuance of initial public offering common stock, net				5,898				5,898
Issuance of initial public offering common stock, net (in shares)			403,407
Unrealized gain (loss) on marketable securities								0
Net loss							(12,267)	(12,267)
Stockholders equity, Ending balance at Sep. 30, 2021			$ 2	195,190			(45,564)	149,628
Stockholders equity, Ending balance (in shares) at Sep. 30, 2021			23,201,971
Stockholders equity, Beginning balance at Dec. 31, 2021			$ 2	195,881			(55,186)	140,697
Stockholders equity, Beginning balance (in shares) at Dec. 31, 2021			23,205,915
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock				5				5
Vesting of restricted common stock (in shares)			11,833
Issuance of common stock upon stock option exercises				19				$ 19
Issuance of common stock upon stock option exercises (in shares)			44,105					44,105
Stock-based compensation				2,347				$ 2,347
Common stock repurchase					$ (31)			(31)
Common stock repurchase (in shares)			38,943
Warrant issuance				380				380
Unrealized gain (loss) on marketable securities						$ (258)		(258)
Net loss							(76,038)	(76,038)
Stockholders equity, Ending balance at Sep. 30, 2022			$ 2	198,632	(31)	(258)	(131,224)	67,121
Stockholders equity, Ending balance (in shares) at Sep. 30, 2022			23,300,796
Stockholders equity, Beginning balance at Jun. 30, 2022			$ 2	197,368	(25)	(275)	(92,387)	104,683
Stockholders equity, Beginning balance (in shares) at Jun. 30, 2022			23,289,064
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock				1				1
Vesting of restricted common stock (in shares)			3,943
Stock-based compensation				883				883
Common stock repurchase					(6)			(6)
Common stock repurchase (in shares)			7,789
Warrant issuance				380				380
Unrealized gain (loss) on marketable securities						17		17
Net loss							(38,837)	(38,837)
Stockholders equity, Ending balance at Sep. 30, 2022			$ 2	$ 198,632	$ (31)	$ (258)	$ (131,224)	$ 67,121
Stockholders equity, Ending balance (in shares) at Sep. 30, 2022			23,300,796